NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Real estate industry wants AML levy exemption
Finance

Real estate industry wants AML levy exemption

The real estate industry is warning an AML levy will drive up costs in the sector.

Michael Neilson 15 Sep 2025
My Net Worth: Matt Wong, iFly CEO
Editor's Picks

My Net Worth: Matt Wong, iFly CEO

“I don't want to see local government shaped by a whole bunch of oldies.” 

Fail File: Vikki Maclean, Kerridge & Partners partner
Editor's Picks

Fail File: Vikki Maclean, Kerridge & Partners partner

“My kids have taught me that you can do whatever you want, but be humble.”

Victoria Carter 13 Sep 2025
Why Savor Group won't sell you lamb cutlets
Markets Small Cap Wrap

Why Savor Group won't sell you lamb cutlets

Plus, its D-day for Tait's Vital takeover, and more.